Respiratory Infections News

Among children with asthma, social risk interventions were associated with decreased asthma-related ED visits and hospitalizations, researchers reported in JAMA Pediatrics.

A final analysis confirmed that Pfizer’s investigational oral antiviral, Paxlovid, reduced the risk for severe COVID-19 outcomes by almost 90% when given within days of symptom onset, as first reported last month, the company said.

Less than 20% of eligible children in the United States have received a first dose of COVID-19 vaccine, and progress has slowed in the last 2 weeks, according the AAP.

In a recent MMWR report, members of the CDC’s COVID-19 Response Team provided details on the first 43 confirmed infections in the United States caused by the omicron variant of SARS-CoV-2.

Results from the CONTAIN COVID-19 trial showed that convalescent plasma did not meet prespecified efficacy endpoints in patients hospitalized with COVID-19.

A blood test at the time of diagnosis can predict the severity of COVID-19-related illness and a patient’s risk for death, according to a small study published in PLoS One.

The FDA’s authorization on Thursday of booster shots for adolescents aged 16 and 17 years came just 2 days before the 1-year anniversary of the first emergency use authorization of a COVID-19 vaccine in the United States.

According to a new report, global funding for tuberculosis research totaled $915 million in 2020 — less than half of the $2 billion goal set at the 2018 United Nations High-Level Meeting on TB.

The FDA on Thursday authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for children aged 16 and 17 years.

Patients with COVID-19 reported sleep, neurological and other symptoms that often lasted for more than a year, according a retrospective, observational analysis at one health care system.